Articles Tagged with ''treatment resistant depression''
Research Update
Dopamine Partial Agonists for Treatment-Resistant Depression
Alla Alexander, MD. Dr. Alexander has no financial relationships with companies related to this material.
Clinical Update
Magnetic Seizure Therapy: A Safer, Gentler Alternative to ECT?
Dee Rapposelli. Ms. Rapposelli has no financial relationships with companies related to this material.
Clinical Update
How Long Should We Continue Esketamine?
Steven Hamilton, MD, PhD. The Permanente Medical Group, Department of Psychiatry, Kaiser Permanente San Francisco Medical Center.
Dr. Hamilton has no financial relationships with companies related to this material.
Clinical Update
Evidence-Based Options for Treatment-Resistant Depression in Older Adults
Julia Cromwell, MD. Medical director, geriatric and adult inpatient psychiatrist at Mass General Brigham Salem Hospital, Salem, MA.
Dr. Cromwell has no financial relationships with companies related to this material.
Research Update
Esketamine vs Quetiapine in Treatment-Resistant Depression
Ivy Song, MD. Dr. Song has no financial relationships with companies related to this material.
Expert Q&A
Ketamine-Assisted Therapy
Kyle T. Greenway, MD, MSc.
Assistant Professor of Psychiatry at McGill University. Director of the ketamine-assisted therapy program at Jewish General Hospital, Montreal, Canada.
Dr. Greenway has no financial relationships with companies related to this material.
Research Update
Ketamine Fails to Outperform Placebo for Depression in Patients Under Anesthesia
Awais Aftab, MD. Dr. Aftab has no financial relationships with companies related to this material.
Carlat Total Access Subscriptions: Get access to every article on the website.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
Recommended
